Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease
Loading...
Citations
Altmetric:
Altmetric::
Download
Associated Records
Authors
File Licence
Editors
Date
2016-01-01
Source Title
Oncotarget
Journal Title
Journal ISSN
Volume Title
Publisher
Impact Journals, LLC
Melbourne Authors
Affiliation
Infectious Diseases
Document Type
Journal Article
Subject Code
Citation
Wang, J., Bi, W., Zhao, W., Varghese, M., Koch, R. J., Walker, R. H., Chandraratna, R. A., Sanders, M. E., Janesick, A., Blumberg, B., Ward, L., Ho, L. & Pasinetti, G. M. (2016). Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease. Oncotarget, 7 (7), pp.7469-7479. https://doi.org/10.18632/oncotarget.7191.
Access Status
Open Access
Access URL
Open Access URL
Open Access at PMC
Linked Resource URL
NHMRC Grant Code
ARC Grant Code
Description
Abstract
Parkinson's disease (PD) is one of the most common movement disorders, and currently there is no effective treatment that can slow disease progression. Preserving and enhancing DA neuron survival is increasingly regarded as the most promising therapeutic strategy for treating PD. IRX4204 is a second generation retinoid X receptor (RXR) agonist that has no cross reactivity with retinoic acid receptors, farnesoid X receptor, liver X receptors or peroxisome proliferator-activated receptor PPARĪ³. We found that IRX4204 promotes the survival and maintenance of nigral dopaminergic (DA) neurons in a dose-dependent manner in primary mesencephalic cultures. Brain bioavailability studies demonstrate that IRX4204 can cross the blood brain barrier and reach the brain at nM concentration. Oral administration of IRX4204 can activate nuclear receptor Nurr1 downstream signaling in the substantia nigra (SN) andattenuate neurochemical and motor deficits in a rat model of PD. Our study suggests that IRX4204 represents a novel, potent and selective pharmacological means to activate cellular RXR-Nurr1 signaling and promote SN DA neuron survival in PD prevention and/or treatment.